Ethyl Ascorbic Acid and Tranexamic Acid: A Formulation Guide

Ethyl ascorbic acid and tranexamic acid can be considered for use in the same cosmetic formulation, particularly in serums developed for uneven skin tone and the appearance of dark spots. However, successful formulation depends on more than the individual properties of these ingredients. Their solubility, pH behavior, concentration, processing conditions, and stability within the finished product must all be evaluated.

For cosmetic formulators, the primary challenge is establishing a formulation environment that accommodates both ingredients without compromising product appearance, analytical stability, or manufacturing consistency. A suitable pH alone does not establish compatibility, and the stability of each ingredient in isolation cannot predict its behavior in a complex serum.

This guide examines the technical considerations behind combining 3-O-Ethyl Ascorbic Acid with Tranexamic Acid, including practical formulation development, analytical testing, raw material specifications, and commercial sourcing requirements.

Ethyl Ascorbic Acid and Tranexamic Acid Compatibility

Ethyl ascorbic acid tranexamic acid compatibility should be assessed through the physicochemical properties of both ingredients and their behavior in the complete formulation.

3-O-Ethyl Ascorbic Acid is an ether derivative of L-ascorbic acid, while Tranexamic Acid is a synthetic derivative of lysine. Their chemical structures and formulation characteristics differ substantially, making it important to evaluate each ingredient independently before assessing their combined performance.

Chemical Properties That Influence Compatibility

3-O-Ethyl Ascorbic Acid, CAS 86404-04-8, has a molecular formula of C₈H₁₂O₆ and a molecular weight of approximately 204.18 g/mol. Its ethyl group is attached at the 3-O position of the ascorbic acid structure.

Research published by Iliopoulos and colleagues reported a pKa of 7.72 ± 0.01 and a logP of −1.07 ± 0.03 for 3-O-Ethyl-L-Ascorbic Acid. These measurements provide useful information about ionization and solvent interactions, although they do not establish a universal formulation pH or predict stability in every cosmetic system.

Tranexamic Acid, CAS 1197-18-8, has a molecular formula of C₈H₁₅NO₂ and a molecular weight of approximately 157.21 g/mol. Its amino and carboxylic acid groups contribute to its acid–base behavior in aqueous solutions.

For formulators investigating 3-o-ethyl ascorbic acid and tranexamic acid, these differences matter when selecting solvents, adjusting pH, and evaluating potential interactions with other formulation components.

Ingredient Compatibility Versus Finished-Product Stability

There is an important distinction between two ingredients being suitable candidates for combination and a finished product having demonstrated long-term stability.

A formulation may initially appear clear and homogeneous but subsequently develop precipitation, discoloration, pH drift, or changes in active ingredient concentration.

These changes may originate from the formulation matrix rather than a direct chemical reaction between the two active ingredients.

Consequently, compatibility should be established through controlled formulation studies rather than assumptions based on ingredient descriptions or separate stability reports.

pH Requirements for Ethyl Ascorbic Acid and Tranexamic Acid Serums

The selection of an appropriate pH is a central consideration in developing an ethyl ascorbic acid and tranexamic acid serum.

Both ingredients must remain sufficiently soluble and chemically stable within the selected formulation environment. However, the ideal pH cannot be determined from the identity of the two active ingredients alone.

Ethyl Ascorbic Acid Stability Across Different pH Conditions

Unlike unmodified L-Ascorbic Acid, 3-O-Ethyl Ascorbic Acid has an ethyl substituent at the 3-O position. This structural modification changes its physicochemical properties and makes it inappropriate to apply every formulation rule developed for conventional L-Ascorbic Acid directly to the ethylated derivative.

The reported pKa of 7.72 ± 0.01 is relevant to ionization behavior, but it should not be interpreted as an optimum stability pH.

When evaluating ethyl ascorbic acid pH stability, formulators should distinguish chemical degradation from physical changes such as crystallization, haze formation, and changes in viscosity.

A formulation can retain an acceptable appearance while experiencing measurable active ingredient loss.

Tranexamic Acid Solubility and pH Behavior

Tranexamic Acid contains both amino and carboxylic acid functional groups, and its ionic state changes with pH.

Its behavior in water-based cosmetic systems is influenced by concentration, temperature, ionic strength, and other dissolved ingredients.

For this reason, tranexamic acid serum pH should be selected alongside solubility and stability measurements rather than from a single recommended number.

Formulators should also assess whether neutralization agents, electrolytes, or thickening polymers affect the clarity and physical stability of the formulation.

Selecting a Practical pH Screening Range

An initial study of ethyl ascorbic acid tranexamic acid pH compatibility could compare otherwise identical formulations at pH 4.5, 5.5, and 6.5.

These values are illustrative experimental conditions, not established optimum pH values or regulatory recommendations.

Each sample should be evaluated for initial appearance, pH drift, active ingredient recovery, viscosity, and physical stability during storage.

The final pH should be selected using the combined results of analytical testing, formulation performance, and the regulatory requirements of the intended market.

Solubility and Concentration Selection in Dual-Active Formulations

Solubility determines whether an active ingredient can be incorporated uniformly and remain dissolved throughout the product's shelf life. For dual-active serums, the combined solute load is particularly important because the addition of one ingredient may alter the solvent environment experienced by the other.

Solubility of Ethyl Ascorbic Acid and Tranexamic Acid in Water-Based Systems

Published research on ethyl ascorbic acid solubility demonstrates that solvent selection can substantially influence ingredient dissolution.

In a study investigating 3-O-Ethyl-L-Ascorbic Acid, Iliopoulos and colleagues reported solubility values of approximately 463.6–801.1 mg/mL across selected hydrophilic solvents, compared with 0.6–56.6 mg/mL across the lipophilic solvents investigated. These ranges describe different experimental solvents and must not be interpreted as the solubility of the ingredient in water alone.

For formulators evaluating tranexamic acid solubility in water, the relevant questions include the intended concentration, solution temperature, pH, and potential effects of other dissolved materials.

Both ingredients may be suitable for aqueous formulations, but their individual dissolution characteristics do not establish the maximum combined concentration that a finished serum can support.

A useful preliminary assessment involves preparing individual ingredient solutions and a combined solution at the intended concentrations. Samples should be examined immediately after preparation and following controlled storage, including lower-temperature conditions where crystallization may become apparent.

Choosing Ingredient Concentrations for Serum Development

The appropriate concentration depends on the intended product positioning, available safety and performance evidence, target market regulations, and formulation stability.

For preliminary laboratory evaluation, a formulator might investigate a system containing 1% 3-O-Ethyl Ascorbic Acid alongside a separately justified concentration of Tranexamic Acid. This is an example of an experimental starting point, not a validated formula or a recommended commercial use level.

Concentration screening should consider ingredient recovery, sensory properties, viscosity, clarity, and storage behavior. Increasing the concentration of either active does not necessarily improve finished-product performance.

A commercially viable formula requires sufficient technical evidence to justify the selected concentrations.

Stability and Discoloration in Ethyl Ascorbic Acid and Tranexamic Acid Serums

Ethyl ascorbic acid stability must be evaluated within the finished formulation, where multiple variables can influence degradation and physical changes.

A dual-active serum may also contain humectants, preservatives, chelating agents, polymers, fragrances, and botanical extracts. Each can influence the formulation environment, making stability assessment more complex than testing two ingredients in purified water.

Temperature, Light and Packaging Considerations

Temperature affects reaction rates, solubility, viscosity, and interactions among formulation components. Elevated temperatures are useful for accelerated stability screening, but accelerated results do not always predict real-time shelf life.

Light exposure and packaging characteristics also deserve consideration. Transparent containers may be appropriate for some systems, while others benefit from packaging that limits light exposure or air exchange.

For tranexamic acid serum stability, the formulation's overall physical and chemical behavior should be monitored rather than assuming that the presence of Tranexamic Acid determines the product's stability.

Packaging studies should compare the intended commercial container with suitable laboratory controls, accounting for closure integrity, material compatibility, and changes during storage.

Investigating Yellowing, Precipitation and Assay Loss

Ethyl ascorbic acid serum discoloration is a useful quality indicator, but a color change alone cannot identify the underlying chemical mechanism.

Yellowing may involve degradation products, interactions with other ingredients, trace contaminants, or changes in the formulation matrix. It should not automatically be attributed to Tranexamic Acid.

Similarly, a serum that remains colorless may still show measurable active ingredient loss.

A practical investigation should distinguish among:

Chemical degradation measured through a suitable analytical method.

Physical instability, including precipitation, haze, or phase separation.

Changes in color, odor, pH, or viscosity.

Ingredient-specific testing is necessary before drawing conclusions about the source of instability.

Developing an Ethyl Ascorbic Acid and Tranexamic Acid Serum

A reliable ethyl ascorbic acid tranexamic acid formulation begins with laboratory-scale process development. The objective is to establish reproducible dissolution, controlled processing, and consistent product characteristics before commercial manufacturing.

Water Phase Preparation and Ingredient Dissolution

The water phase should be prepared using water of appropriate cosmetic manufacturing quality.

Each active ingredient can initially be dissolved in a separate portion of the formulation's solvent system. This approach allows formulators to assess dissolution behavior independently and identify potential difficulties before combining the solutions.

A practical development sequence is to prepare the base, dissolve the active ingredients under controlled conditions, combine the solutions, and adjust the final formulation as necessary.

The sequence should be verified experimentally because the best addition order may change with the presence of polymers, electrolytes, or other ingredients.

Processing Temperature and pH Adjustment

Processing temperature should be controlled to minimize unnecessary thermal exposure.

Where practical, active ingredients can be introduced during a cooler processing stage, provided dissolution and mixing remain satisfactory. A temperature below 40°C may be considered as an initial development precaution, but it should not be presented as a universally established processing limit.

The final pH should be measured after the ingredients have been incorporated and the formulation has equilibrated.

For tranexamic acid skincare formulation development, pH adjustment should be gradual and supported by subsequent stability testing.

From Laboratory Batches to Commercial Production

Laboratory success does not automatically translate into commercial manufacturing.

Scale-up can change mixing time, shear exposure, heat transfer, and the rate at which ingredients dissolve. These differences may influence product uniformity and physical stability.

Before production, manufacturers should establish suitable process controls and confirm that the selected manufacturing equipment and packaging materials are compatible with the formulation.

For an ethyl ascorbic acid cosmetic formulation, representative pilot batches should be evaluated before approving a commercial manufacturing process.

Stability Testing and Quality Control for Dual-Active Serums

A structured testing program provides stronger evidence of formulation compatibility than visual inspection alone.

HPLC Assay and Ingredient-Specific Analytical Methods

An ethyl ascorbic acid HPLC assay can be used to monitor the concentration of 3-O-Ethyl Ascorbic Acid during formulation development and stability studies.

However, the analytical method must demonstrate sufficient specificity in the actual formulation matrix. Other ingredients, degradation products, and preservatives may interfere with detection or quantification.

Tranexamic Acid requires an appropriate validated or suitably qualified analytical method as well. A method developed for one active should not be assumed to quantify both ingredients accurately.

Where possible, the analytical program should include initial assay, recovery assessment, repeatability, and evaluation of potential interfering peaks.

Accelerated Stability and Packaging Compatibility

Cosmetic serum stability testing should combine physical observations with quantitative analysis.

A useful experimental design includes four formulations:

Formulation	Active ingredients	Purpose
Control A	Base without either active	Evaluate changes originating from the formulation base
Control B	Ethyl Ascorbic Acid only	Establish its behavior in the selected base
Control C	Tranexamic Acid only	Establish its behavior independently
Test D	Both active ingredients	Evaluate the combined formulation

Each formulation should be assessed using comparable packaging, storage conditions, and analytical procedures.

Testing may include elevated-temperature storage, real-time observation, pH monitoring, viscosity, appearance, and active ingredient assay. Freeze–thaw or low-temperature studies may also be relevant, depending on the product.

The results should be interpreted according to predefined acceptance criteria. An accelerated study alone should not be used to claim a definitive commercial shelf life.

Cosmetic-Grade Ethyl Ascorbic Acid: Specifications and Raw Material Quality

The performance of a cosmetic formulation depends partly on the consistency of its incoming raw materials. For commercial production, purchasing decisions should therefore consider analytical specifications, impurity profiles, documentation, and batch-to-batch reproducibility.

Purity, Identity and Batch Documentation

When sourcing cosmetic grade ethyl ascorbic acid, buyers should confirm the ingredient's chemical identity and the analytical method used to determine its purity.

CHEN LANG BIO TECH supplies 3-o-ethyl ascorbic acid 99% as a white to off-white crystalline powder for cosmetic formulation development.

The following information is particularly relevant to purchasing and quality assurance teams.

Parameter	Raw material information or purchasing requirement
INCI name	3-O-Ethyl Ascorbic Acid
CAS number	86404-04-8
Molecular formula	C₈H₁₂O₆
Molecular weight	204.18 g/mol
Appearance	White to off-white crystalline powder
Assay	≥99%
Analytical documentation	Batch-specific COA and applicable test methods
Additional quality information	Impurities, moisture and other relevant specifications according to the approved material standard
Commercial packaging	1–5 kg aluminum foil bags; 25 kg paper drums

A current ethyl ascorbic acid COA should be reviewed against the agreed purchasing specification rather than treated as a substitute for the supplier's complete technical documentation.

Evaluating Cosmetic Raw Materials Before Scale-Up

Before approving ethyl ascorbic acid powder for commercial use, formulators should compare laboratory samples with the proposed production material.

Differences in particle characteristics, moisture, impurity levels, or storage history can influence handling and formulation performance.

For long-term manufacturing programs, procurement teams should also review change-control arrangements, batch traceability, storage recommendations, and the supplier's ability to provide consistent analytical documentation.

These considerations are particularly important when the ingredient will be incorporated into a formulation requiring extensive stability validation.

Bulk Ethyl Ascorbic Acid Sourcing for Cosmetic Manufacturers

Selecting an ethyl ascorbic acid manufacturer involves more than comparing nominal assay values. Buyers should assess whether the material is supported by appropriate documentation, reproducible quality, and practical technical assistance.

For brands developing a dual-active serum, it is useful to obtain an evaluation sample before committing to commercial quantities. Laboratory testing can establish whether the supplied material performs satisfactorily in the intended formulation.

Supplier Evaluation, Packaging and Commercial Orders

As an ethyl ascorbic acid supplier, CHEN LANG BIO TECH supports cosmetic ingredient sourcing with 99% material specifications and relevant quality documentation.

Our standard packaging options include 1–5 kg aluminum foil bags and 25 kg paper drums, accommodating both smaller development orders and larger manufacturing requirements.

For bulk ethyl ascorbic acid inquiries, buyers can provide their target quantity, destination market, documentation requirements, and expected purchasing schedule.

Requests for ethyl ascorbic acid price per kg should also specify the anticipated order volume and shipping destination, since commercial quotations depend on these factors.

For wholesale ethyl ascorbic acid purchasing, confirming the required specification and packaging before quotation helps avoid unnecessary revisions.

An ethyl ascorbic acid sample can be evaluated against the customer's own formulation and quality criteria before a larger order is approved.

Companies planning to buy ethyl ascorbic acid powder should request the latest batch documentation and confirm that the offered grade meets their intended cosmetic application.

Frequently Asked Questions About Ethyl Ascorbic Acid and Tranexamic Acid

Can ethyl ascorbic acid and tranexamic acid be used in the same serum?

Both ingredients can be considered for incorporation into a single cosmetic serum. However, their combined use requires evaluation of solubility, pH, chemical stability, and compatibility with the complete formulation. Successful laboratory preparation does not independently establish commercial shelf life.

What pH should formulators consider for this combination?

There is no universally validated optimum pH for every formulation containing these two ingredients. Formulators should screen a suitable range and select the final pH based on ingredient recovery, physical stability, formulation performance, and applicable regulatory requirements.

Can tranexamic acid affect the color or stability of an ethyl ascorbic acid serum?

The presence of Tranexamic Acid does not, by itself, establish a cause of discoloration or degradation. Any observed change should be investigated through appropriate controls, analytical testing, and comparison with formulations containing each active separately.

What documents should buyers request for cosmetic-grade ethyl ascorbic acid?

Buyers should request a current COA, specification sheet, safety data sheet, and relevant technical information. Depending on the intended market and application, additional documentation concerning impurities, traceability, regulatory status, and manufacturing quality may also be necessary.

Conclusion: Building a Stable Dual-Active Cosmetic Formula

Combining ethyl ascorbic acid and tranexamic acid in a cosmetic formulation requires a systematic approach to ingredient compatibility, pH selection, dissolution, processing, and stability validation.

The chemical characteristics of each ingredient provide a useful starting point, but commercial formulation decisions should be supported by testing in the complete product matrix.

For cosmetic manufacturers, raw material consistency is equally important. Verified identity, appropriate assay specifications, batch documentation, and reliable supply arrangements help support reproducible manufacturing and long-term quality control.

CHEN LANG BIO TECH supplies 99% 3-O-Ethyl Ascorbic Acid for cosmetic formulation development and commercial manufacturing.

For technical specifications, batch documentation, sample availability, or ethyl ascorbic acid bulk powder quotations, contact our team at admin@chenlangbio.com.

References

1. Iliopoulos, F., et al. (2019). 3-O-Ethyl-L-Ascorbic Acid: Characterisation and Investigation of Single Solvent Systems for Delivery to the Skin. International Journal of Pharmaceutics: X, 1, 100025. https://doi.org/10.1016/j.ijpx.2019.100025

2. Iliopoulos, F., et al. (2020). Topical Delivery of 3-O-Ethyl-L-Ascorbic Acid from Complex Solvent Systems. Scientia Pharmaceutica, 88(2), 19. https://doi.org/10.3390/scipharm88020019

3. Maeda, K., & Naganuma, M. (1998). Topical Trans-4-Aminomethylcyclohexanecarboxylic Acid Prevents Ultraviolet Radiation-Induced Pigmentation. Journal of Photochemistry and Photobiology B: Biology, 47(2–3), 136–141.

4. ISO/TR 18811:2018. Cosmetics — Guidelines on the Stability Testing of Cosmetic Products. International Organization for Standardization.

5. International Council for Harmonisation (ICH). Q2(R2): Validation of Analytical Procedures. 2023. A pharmaceutical analytical validation reference that may inform method-development principles; not a cosmetic-specific mandatory standard.

6. European Commission. CosIng — Cosmetic Ingredient Database. Reference resource for ingredient identification and regulatory screening. Inclusion in the database does not itself constitute authorization for cosmetic use.

7. European Union. Regulation (EC) No 1223/2009 on Cosmetic Products, as amended. Relevant to evaluating cosmetic product compliance in the EU.